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Background
Sublingual immunotherapy (SLIT) is considered as a
valid alternative in treatment of patients suffering house
dust mite (HDM) allergic rhinitis. No evaluation of the
patients’ satisfaction on treatment and its relationship
with clinical improvement and compliance was pre-
viously described.
Methods
An observational cross-sectional study was carried out
to compare patients’ satisfaction after 4-6 months
(group A) or 9-12 months (group B) of SLIT treatment
by the use of a validated Spanish satisfaction question-
naire (ESPIA) consisting of 16 items on a 5-point Likert
scale (scale 16-80, higher score indicating more satisfac-
tion). Secondary objectives were to investigate relation
between satisfaction and both clinical improvement and
compliance. Patients were classified in terms of compli-
ance into <25%; 25-50%, 51-75%; >76% group.
Results
Data from 232 patients (162 in A and 70 in B) were col-
lected. In group A, 72% of them had persistent and 96%
moderate-severe rhinitis before starting immunotherapy.
Similarly in group B, 68% of them had persistent and
97% moderate-severe rhinitis. Treatment duration was
5.5±1.7 months in A and 12.3±2.5 months in B. Median
total satisfaction was 60 and 73 points in A and B
respectively. In those patients reporting compliance >
76% (n=191) higher median values of satisfaction
(ESPIA score) were found in group B (P<0.0001).
Patients changing from persistent to intermittent rhinitis
between start of SLIT and current situation were 49%
and 60% in A and B respectively. Concerning severity
according to ARIA guidelines, patients changing from
moderate-severe to mild were 43% and 72% in A and B
respectively (group effect, p=0.0003). In those patients
reporting clinical improvement in terms of rhinitis fre-
quency (n=108) higher median values of satisfaction
were found in group B (P=0.0007) and similarly, patients
reporting clinical improvement in terms of rhinitis
severity (n=151), higher median values of satisfaction
were found in group B (P<0.0001).
Conclusions
Almost 50% of the patients treated 5.5 months experi-
enced an improvement of their rhinitis in terms of fre-
quency (49%) and severity (43%), this percentage is
higher in patients treated 12.3 months 60% and 72%
respectively following ARIA classification.The SAMITES
study demonstrates a clear relationship between
patients’ satisfaction with SLIT for HDM allergic rhinitis
with the duration of treatment, compliance and clinical
improvement.
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